Related Experiment Video
Updated: Jun 21, 2026
07:35
Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
Published on: January 26, 2024
Rab34 and its effector munc13-2 constitute a new pathway modulating protein secretion in the cellular response to
Neil M Goldenberg1, Mel Silverman
1Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
American Journal of Physiology. Cell Physiology
|July 31, 2009
Summary
High glucose levels stimulate protein secretion in diabetic nephropathy through a pathway involving munc13 and rab34. This newly identified mechanism highlights a potential role in the disease
Area of Science:
- Cell Biology
- Endocrinology
- Nephrology
Background:
- Diabetic nephropathy (DN) is a leading cause of end-stage renal disease.
- Hyperglycemia is a key driver of diabetic complications.
- Understanding cellular responses to high glucose is crucial for DN pathogenesis.
Purpose of the Study:
- To identify novel pathways linking hyperglycemia to cellular dysfunction in DN.
- To investigate the role of munc13 and rab34 in high glucose-induced protein secretion.
Main Methods:
- Utilized cultured rat mesangial cells (RMC) and HeLa cells.
- Employed small interfering (si)RNA to knockdown munc13-2 and rab34.
- Assessed secretion of vesicular stomatitis virus glycoprotein-green fluorescent protein (VSVG-GFP) and fibronectin.
Main Results:
- High glucose upregulated munc13-2 in RMC, increasing VSVG-GFP secretion.
- Knockdown of munc13-2 or rab34 abolished high glucose-induced VSVG-GFP secretion.
- Munc13's munc13 homology domain 2 (MHD2) is essential for this effect.
- High glucose-stimulated fibronectin secretion in RMC was abolished by munc13-2 knockdown.
Conclusions:
- A novel pathway involving munc13 and rab34 mediates high glucose-induced protein secretion.
- This pathway plays a significant role in the pathogenesis of diabetic nephropathy.
- Targeting the munc13-rab34 interaction may offer therapeutic strategies for DN.
Related Concept Videos
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...